NAMD Responds to Medicaid Access RFI

NAMD submitted comments to a Centers for Medicare and Medicaid Services (CMS) Request for Information (RFI) to provide key considerations around Medicaid access monitoring measures. NAMD recommends that CMS must allow states to retain authority over their reimbursement rates, as well as prioritize high-value measures that target specific program priorities and minimize overall reporting burden […]

Continue reading

NAMD submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to CMS’s final rule on monitoring access to Medicaid services. The letter requests a delay in the initial submission date for state access monitoring plans, that states heavily invested in Medicaid managed care be exempted from the rule’s requirements, and discusses […]

Continue reading

NAMD Supports Revising Medicare Risk Model

NAMD submitted comments in response to the Centers for Medicare and Medicaid Services (CMS) proposed changes to the CMS-Hierarchical Condition Category (HCC) risk adjustment model for plan year 2017. Alignment of Medicare and Medicaid payment policies is increasingly important to states’ work to drive person-centered systems that address the continuum of complex service needs for […]

Continue reading

NAMD submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the development of the Medicare and multi-payer provider incentive program created under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The letter, which responds to CMS’ request for information, offers insight on the inclusion of Medicaid alternative payment models in the program […]

Continue reading

NAMD submitted comments in response to CMS’ paper, “Medicaid Services ‘Received Through’ an Indian Health Service/Tribal Facility: A Request for Comment”. The paper seeks to revise interpretation of Section 1905 (b) of the Act to move towards parity in the federal matching rate for services furnished through Indian Health Services (IHS) or “638” tribally-operated health […]

Continue reading

NAMD Comments on 340B Omnibus Guidance

NAMD submitted comments to the Health Resources and Services Administration (HRSA)’s proposed omnibus guidance addressing several aspects of the 340B drug discount program. Read the full comments.

Continue reading

Today, NAMD urged Congressional committees of jurisdiction to take immediate action to avert the 52% increase in Medicare Part B premiums slated to take effect on January 1, 2016. The letter notes that the financial burden of this increase falls primarily on Medicaid programs, as the premium increase applies to only 30% of Part B […]

Continue reading

NAMD Comments on 340B Ceiling Price Rule

NAMD provided written comments to the Health Resources and Services Administration on its proposed rule addressing ceiling prices and manufacturer civil monetary penalties in the 340B drug discount program. Read the full letter here.

Continue reading

Today, the National Association of Medicaid Directors submitted comments to Vicki Wachino, Director, Center for Medicaid & CHIP Services, Centers for Medicare & Medicaid Services at the U.S. Department of Health and Human Services on the proposed rule, Medicaid and Children’s Health Insurance Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies and Revisions […]

Continue reading

NAMD Gives Testimony on 1115 Waivers

Today, Matt Salo, executive director of the National Association of Medicaid Directors, gave testimony before the Energy and Commerce Committee, Subcommittee on Health on “Examining the Administration’s Approval of Medicaid Demonstration Projects.” Read the full testimony here.

Continue reading